Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents
Clinical trial NCT01210885 · COMPLETED
Trial details
- NCT number
- NCT01210885
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 495
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.